Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Treasury Shares: 2020-2024

Historic Treasury Shares for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $2.3 million.

  • Journey Medical's Treasury Shares fell 23.63% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 23.63%. This contributed to the annual value of $2.3 million for FY2024, which is 79.04% up from last year.
  • Per Journey Medical's latest filing, its Treasury Shares stood at $2.3 million for FY2024, which was up 79.04% from $1.3 million recorded in FY2023.
  • Over the past 5 years, Journey Medical's Treasury Shares peaked at $2.3 million during FY2024, and registered a low of $715,030 during FY2021.
  • For the 3-year period, Journey Medical's Treasury Shares averaged around $2.0 million, with its median value being $2.3 million (2022).
  • Per our database at Business Quant, Journey Medical's Treasury Shares soared by 216.22% in 2022 and then crashed by 42.20% in 2023.
  • Journey Medical's Treasury Shares (Yearly) stood at $815,524 in 2020, then fell by 12.32% to $715,030 in 2021, then skyrocketed by 216.22% to $2.3 million in 2022, then plummeted by 42.20% to $1.3 million in 2023, then skyrocketed by 79.04% to $2.3 million in 2024.